Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 3,995 | 1,727 | 1,701 | 3,630 | 4,643 |
| Gross Profit | 3,995 | 1,727 | 1,701 | 3,630 | 4,643 |
| Operating Expenses | 23,015 | 20,203 | 24,522 | 29,513 | 22,628 |
| Operating Income | -19,020 | -18,476 | -22,821 | -25,883 | -17,985 |
| Other Income | 84 | 975 | -437 | 897 | 268 |
| Pre-tax Income | -18,936 | -17,501 | -23,258 | -24,986 | -17,717 |
| Net Income Continuous | -18,936 | -17,501 | -23,258 | -24,986 | -17,717 |
| Net Income | $-18,936 | $-17,501 | $-23,258 | $-24,986 | $-17,717 |
| EPS Basic Total Ops | -0.86 | -0.85 | -1.22 | -1.37 | -0.95 |
| EPS Basic Continuous Ops | -0.86 | -0.85 | -1.19 | -1.37 | -0.95 |
| EPS Diluted Total Ops | -0.86 | -0.85 | -1.22 | -1.37 | -0.95 |
| EPS Diluted Continuous Ops | -0.86 | -0.85 | -1.19 | -1.37 | -0.95 |
| EBITDA(a) | $-18,829 | $-18,286 | $-22,632 | $-25,994 | $-17,496 |